Clinic
Methodist Health Centers
Methodist Health Centers was paid $6.16M by Medicaid between Dec 2019 and Nov 2024, across 63 billing codes. Its largest line is 99284, emergency room visit (serious) — 71% of everything it billed.
33Billing provider infoMETHODIST HEALTH CENTERS
HOUSTON, TX 77094
HOUSTON, TX 77094
33aNPI1083937593assigned 03/11/2010
33bProvider typeAmbulatory Surgical Clinic/Center
28Total paid$6.16M
24GClaims74,799
24DCodes billed63
24AFirst – last monthDec 2019 – Nov 2024
Compared with peers
Next to other Ambulatory Surgical Clinic/Center providers in Texas
Rank by total paid#68 of 320
Median peer was paid$205K
This provider vs. median30×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 28 | $137.75 | |
| 2020 | 2,080 | $233K | |
| 2021 | 19,304 | $1.45M | |
| 2022 | 22,838 | $2.11M | |
| 2023 | 19,942 | $1.91M | |
| 2024incomplete | 10,607 | $464K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 71% | 6,406 | 6,055 | $4.38M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 9.3% | 2,028 | 1,879 | $571K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | 3.3% | 509 | 499 | $206K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 2.6% | 1,841 | 1,752 | $159K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 2.5% | 1,810 | 1,737 | $155K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1.7% | 1,881 | 1,701 | $108K |
| 80053 | Comprehensive metabolic panel | 1.5% | 12,858 | 11,576 | $95K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.0% | 13,237 | 11,728 | $62K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 358 | 341 | $61K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 2,841 | 2,692 | $53K |
| 76801 | <1% | 506 | 441 | $50K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 335 | 293 | $28K |
51 more codes
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 125 | $25K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 1,214 | $23K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 488 | $23K |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | <1% | 747 | $18K |
| 71045 | Radiologic examination, chest; single view | <1% | 1,394 | $17K |
| G0378 | Hospital observation service, per hour | <1% | 329 | $16K |
| 84703 | <1% | 2,867 | $14K | |
| 83880 | <1% | 1,331 | $13K | |
| 81001 | <1% | 4,891 | $12K | |
| 84484 | <1% | 2,842 | $10K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 1,127 | $9K |
| 87088 | <1% | 1,535 | $7K | |
| 84702 | <1% | 717 | $7K | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 98 | $4K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 44 | $4K |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 180 | $4K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 413 | $3K |
| 86850 | <1% | 169 | $3K | |
| 83690 | <1% | 945 | $3K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 40 | $3K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 24 | $2K |
| 86901 | <1% | 905 | $2K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 845 | $2K |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 548 | $2K |
| 85730 | <1% | 718 | $2K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,291 | $2K |
| 85610 | <1% | 971 | $1K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 82 | $1K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 327 | $1K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 457 | $858.98 |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 44 | $838.35 |
| CP007 | <1% | 14 | $686.00 | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 25 | $638.06 |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 54 | $626.39 |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 635 | $532.62 |
| 86900 | <1% | 229 | $514.67 | |
| 87077 | <1% | 131 | $384.52 | |
| 87400 | <1% | 30 | $261.76 | |
| 83735 | <1% | 99 | $248.65 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 96 | $242.40 |
| 81025 | <1% | 41 | $200.03 | |
| 87070 | <1% | 33 | $180.12 | |
| 83605 | <1% | 96 | $163.88 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 41 | $44.21 |
| 87040 | <1% | 24 | $34.68 | |
| 82550 | <1% | 19 | $27.35 | |
| 87186 | <1% | 12 | $14.54 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 16 | $2.97 |
| 36415 | Collection of venous blood by venipuncture | <1% | 764 | $1.80 |
| J2704 | Injection, propofol, 10 mg | 0% | 108 | $0.00 |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | 0% | 14 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialVOSS, WAYNE (CEO)